Composition
- Active ingredients
- PREDNISOLONE SODIUM PHOSPHATE EQ 0.23% PHOSPHATE; SULFACETAMIDE SODIUM 10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA018988.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Vasocidin
- Active substance
- prednisolone sodium phosphate
- Route
- Eye
- Dosage form
- Solution/drops
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 26 Aug 1988
- Application
- NDA018988-001